MYP_103875
T21N17
Antimicrobial
Antiviral
▸
Anti-HIV
▸
Antiviral
▸
Antiviral mechanism
▸
Standard
38 amino acids
C210H354N64O56
Standard
RIQQIEQKIHHIEQRIQQIEQLLQLTVWGIKQLQARIL
4671.45 Da
9.98
1.94
1.63
0.0511
-0.37
0.62
-0.07
103.59
143.68
0.0263
5500.00
5500.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
2013.94
-14.42
67.0
60.0
168.0
330.0
4.0
47.0
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0207245
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
HIV-1
RECORD: Rec_0310145
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
None
Disulfide bond(s) reported
Bio-Activity Profile
Antimicrobial
HIV-1(human immunodeficiency virus 1):inhiition of cell-cell fusion between TZM-bl cells and HL2/3 cells
0.251±0.0411 μM
IC50
RECORD: Rec_0341415
VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
None
Bio-Activity Profile
Anti-HIV-1
Fusion inhibition
HIV-1 (human immunodeficiency virus 1) | TZM-bl cells; HL2/3 cells
0.251±0.0411 μM
IC50
Mammalian: 1 h; Yeast: 2 min; E. coli: 2 min